Morning, Thursday, 26th March 2020
THIS EVENT IS CPD CERTIFIED
This conference will consider the future of health research in England.
It is timed to bring together stakeholders and policymakers to assess the future regulation of research and clinical trials - including supporting collaboration between the NHS, industry and academia, and ensuring the UK remains an attractive place to carry out research.
We also expect discussion to reflect the announcement in the Queen’s Speech of a Medicines and Medical Devices Bill - expected to enter its second reading in March 2020 - which aims to ensure the UK takes a key role in global research post-Brexit to develop advanced therapies and diagnostics to improve patient care, including commitments to:
- Prioritise science research and skills through investment;
- Adapt the process for low-risk clinical trials to remove barriers to the uptake of new innovations;
- Increase funding for dementia research; and
- Support the development of the life sciences sector in the UK.
The agenda includes keynote addresses from: Professor David Crossman, Chief Scientist, Health, NHS Scotland and Dr Louise Wood, Director, Science, Research and Evidence, Department of Health and Social Care.
Further keynote contributors include: Dr Janet Allen, Cystic Fibrosis Trust; Teresa Allen, Health Research Authority; John Craig, Care City; Dr Axel Heitmueller, Imperial College Health Partners and Professor Matt Westmore, University of Southampton.
Also speaking are: Professor Ian Hall, Faculty of Medicine and Health Sciences, University of Nottingham; Christine McGrath, University Hospital Southampton NHS Foundation Trust and UKRD; Dr Sheuli Porkess, ABPI and Dr Neville Young, Yorkshire and Humber Academic Health Science Network.
The chairs are: Lord Butler of Brockwell, Non-Executive Director, King’s Health Partners and Lord Sharkey, Chair, Association of Medical Research Charities.
The agenda in summary
- Priorities for health research policy in England - looking at public and private investment, and the wider research environment;
- Encouraging research uptake - regulation, safeguarding data, and navigating the approval process:
- Regulation of research and clinical trials;
- Utilising data-protection, appropriate sharing, and maintaining public trust;
- Transparency in research - reproducibility, reporting results, and impact;
- Patient and public engagement in health research; and
- Opportunities for learning from the NHS Test Beds Programme - a case study.
- Health research and the research workforce - funding, the impact of Brexit, and encouraging cross-sector collaboration; and
- Ensuring the UK remains an attractive place to carry out clinical research.
Engagement with policy officials at this conference
Westminster Health Forum conferences typically attract strong interest from policymakers. This seminar will be an opportunity for stakeholders to engage with officials who have reserved places representing: the DHSC; DIT; HM Treasury; MHRA and Office for Life Sciences.